Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia
Authors
Keywords
-
Journal
BLOOD
Volume 122, Issue 20, Pages 3521-3532
Publisher
American Society of Hematology
Online
2013-09-07
DOI
10.1182/blood-2013-03-493163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Blocked Autophagy Using Lysosomotropic Agents Sensitizes Resistant Prostate Tumor Cells to the Novel Akt Inhibitor AZD5363
- (2012) F. Lamoureux et al. CLINICAL CANCER RESEARCH
- mTORC1 is essential for leukemia propagation but not stem cell self-renewal
- (2012) Takayuki Hoshii et al. JOURNAL OF CLINICAL INVESTIGATION
- Single-vector inducible lentiviral RNAi system for oncology target validation
- (2011) Dmitri Wiederschain et al. CELL CYCLE
- L-Asparaginase and Inhibitors of Glutamine Synthetase Disclose Glutamine Addiction of β-Catenin-Mutated Human Hepatocellular Carcinoma Cells
- (2011) CURRENT CANCER DRUG TARGETS
- The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia
- (2011) L Willems et al. LEUKEMIA
- Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
- (2011) Weidong Han et al. PLoS One
- Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
- (2010) Yasemin Sancak et al. CELL
- Targeting autophagy to fight hematopoietic malignancies
- (2010) Alexandre Puissant et al. CELL CYCLE
- Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
- (2010) N. Chapuis et al. CLINICAL CANCER RESEARCH
- Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
- (2010) Celine Callens et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
- (2010) M. G. Vander Heiden et al. SCIENCE
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
- (2010) A. J. Levine et al. SCIENCE
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia
- (2009) J. Tamburini et al. BLOOD
- Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
- (2009) Paul Nicklin et al. CELL
- Amino acid regulation of TOR complex 1
- (2008) Joseph Avruch et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Regulation of TORC1 by Rag GTPases in nutrient response
- (2008) Eunjung Kim et al. NATURE CELL BIOLOGY
- The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
- (2008) Y. Sancak et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More